-
公开(公告)号:US20050260651A1
公开(公告)日:2005-11-24
申请号:US11105279
申请日:2005-04-13
申请人: Pericles Calias , Gary Cook , David Shima , Anthony Adamis , Yin-Shan Ng , Gregory Robinson , David Turner , Mary Ganley
发明人: Pericles Calias , Gary Cook , David Shima , Anthony Adamis , Yin-Shan Ng , Gregory Robinson , David Turner , Mary Ganley
IPC分类号: A61K31/716 , A61K31/785 , A61K47/48 , A61K49/00 , C08G63/48 , C12Q1/68
CPC分类号: A61K49/0002 , A61K47/60 , A61K47/61
摘要: The invention provides compositions and methods for making and using sterically enhanced antagonist aptamer conjugates that include a nucleic acid sequence having a specific affinity for a target molecule and a soluble, high molecular weight steric group that augments or facilitates the inhibition of binding to, or interaction with, the target molecule binding partner by the target molecule when bound to the aptamer conjugate. The present invention also provides methods and formulations for ocular delivery of a biologically active molecule by attaching a charged moiety to the biologically active molecule and delivering the biologically active molecule by iontophoresis. Iontophoresis of a biologically active molecule that is conjugated to a high molecular weight neutral moiety, in enhanced by substituting the high molecular weight neutral moiety with a charged molecule of comparable size.
摘要翻译: 本发明提供了制备和使用空间增强的拮抗剂适体缀合物的组合物和方法,其包括对靶分子具有特异性亲和力的核酸序列和增加或促进抑制结合或相互作用的可溶性高分子量空间基团 当靶分子与适配体缀合物结合时,靶分子结合配偶体。 本发明还提供了通过将带电部分附着到生物活性分子并通过离子电渗递送生物活性分子来生物活性分子的眼部递送的方法和制剂。 通过与具有相当大小的带电分子取代高分子量中性部分来增强与高分子量中性部分缀合的生物活性分子的离子电渗疗法。
-
公开(公告)号:US08877229B2
公开(公告)日:2014-11-04
申请号:US11607382
申请日:2006-12-01
CPC分类号: A61K38/1866 , A61K9/0019 , A61K9/0048 , A61K9/1647 , A61K31/00
摘要: Formulations for controlled, sustained release of biologically active agents for the treatment of ocular disorders have been developed. These formulations are based on solid microparticles formed of the combination of biodegradable, synthetic polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and copolymers thereof. The microparticles are characterized by low burst levels and efficient drug loading and sustained release.
摘要翻译: 已经开发了用于治疗眼部疾病的生物活性剂的受控持续释放的制剂。 这些制剂基于由可生物降解的合成聚合物如聚(乳酸)(PLA),聚(乙醇酸)(PGA)及其共聚物的组合形成的固体微粒。 微粒的特征在于低爆发水平和有效的药物负载和持续释放。
-
公开(公告)号:US07785784B2
公开(公告)日:2010-08-31
申请号:US11186660
申请日:2005-07-21
申请人: David T. Shima , Pericles Calias , Gregory S. Robinson , John P. Wing , Lori M. Mullin , Lillian M. Smith , Ervin Sinani
发明人: David T. Shima , Pericles Calias , Gregory S. Robinson , John P. Wing , Lori M. Mullin , Lillian M. Smith , Ervin Sinani
CPC分类号: C12Q1/6837 , C12Q1/6816 , C12Q2561/125 , C12Q2561/101 , C12Q2525/205 , C12Q2533/107 , C12Q2537/125 , C12Q2531/113 , C12Q2525/155
摘要: The invention provides methods and compositions for detecting and/or quantifying modified nucleic acid oligonucleotides. These methods and compositions are useful for detecting and quantifying diagnostic and/or therapeutic synthetic modified oligonucleotides, such as aptamers, RNAi, siRNA, antisense oligonucleotides or ribozymes in a biological sample.
摘要翻译: 本发明提供了用于检测和/或定量修饰的核酸寡核苷酸的方法和组合物。 这些方法和组合物可用于检测和定量诊断和/或治疗合成修饰的寡核苷酸,例如生物样品中的适体,RNAi,siRNA,反义寡核苷酸或核酶。
-
公开(公告)号:US20070292475A1
公开(公告)日:2007-12-20
申请号:US11607382
申请日:2006-12-01
申请人: Kathleen Campbell , Pericles Calias , Gary Cook , Mary Ganley
发明人: Kathleen Campbell , Pericles Calias , Gary Cook , Mary Ganley
CPC分类号: A61K38/1866 , A61K9/0019 , A61K9/0048 , A61K9/1647 , A61K31/00
摘要: Formulations for controlled, sustained release of biologically active agents for the treatment of ocular disorders have been developed. These formulations are based on solid microparticles formed of the combination of biodegradable, synthetic polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and copolymers thereof. The microparticles are characterized by low burst levels and efficient drug loading and sustained release.
摘要翻译: 已经开发了用于治疗眼部疾病的生物活性剂的受控持续释放的制剂。 这些制剂基于由可生物降解的合成聚合物如聚(乳酸)(PLA),聚(乙醇酸)(PGA)及其共聚物的组合形成的固体微粒。 微粒的特征在于低爆发水平和有效的药物负载和持续释放。
-
公开(公告)号:US06749865B2
公开(公告)日:2004-06-15
申请号:US09784402
申请日:2001-02-15
申请人: Pericles Calias , Robert J. Miller
发明人: Pericles Calias , Robert J. Miller
IPC分类号: A61K900
CPC分类号: A61K47/645 , A61K47/61 , Y10S530/812 , Y10S530/816
摘要: A biologically active conjugate is disclosed comprising a biopolymer and a therapeutic agent joined by a disulfide bond. The conjugate, when formulated in a pharmaceutical composition with a suitable carrier, has improved in vivo stability and activity, and can be targeted to a variety of cells, tissues and organs.
摘要翻译: 公开了包含通过二硫键连接的生物聚合物和治疗剂的生物活性缀合物。 当配制在具有合适载体的药物组合物中时,缀合物具有改善的体内稳定性和活性,并且可以靶向各种细胞,组织和器官。
-
公开(公告)号:US07456220B2
公开(公告)日:2008-11-25
申请号:US11176701
申请日:2005-07-07
IPC分类号: A61K31/17
CPC分类号: A61K45/06 , A61K31/17 , A61K31/265 , A61K31/452 , A61K31/5375 , Y02A50/402 , Y02A50/473 , Y10S514/825
摘要: The invention relates to immunomodulatory compositions and related methods. The immunomodulatory compositions of a formula disclosed herein are useful for the prevention of sepsis and the treatment and prevention of diseases associated with inflammation and/or NOS.
摘要翻译: 本发明涉及免疫调节组合物和相关方法。 本文公开的式的免疫调节组合物可用于预防败血症和治疗和预防与炎症和/或NOS相关的疾病。
-
公开(公告)号:US07189413B2
公开(公告)日:2007-03-13
申请号:US10075184
申请日:2002-02-14
CPC分类号: A61K9/1647 , A61K9/1617 , A61K9/2013 , A61K9/204 , A61K38/09 , C07K16/28
摘要: Degradable blend of polycaprolactone and crystallization modifier especially suitable for use in the controlled release of biologically active proteins
摘要翻译: 聚己内酯和结晶改性剂的可降解共混物特别适用于生物活性蛋白质的控制释放
-
公开(公告)号:US06610669B1
公开(公告)日:2003-08-26
申请号:US09469638
申请日:1999-12-22
申请人: Pericles Calias , Robert J. Miller
发明人: Pericles Calias , Robert J. Miller
IPC分类号: A61K31715
CPC分类号: A61K9/0019 , A61K9/0014 , A61K47/36 , A61K47/38 , A61L24/08 , A61L27/20 , A61L27/52 , A61L31/041 , A61L31/042 , A61L31/14 , A61L31/145 , A61L31/16 , A61L2300/00 , C08B11/20 , C08B33/00 , C08B33/04 , C08B37/00 , C08B37/0063 , C08B37/0069 , C08B37/0072 , C08B37/0075 , C08L5/08 , C08L2666/02 , C08L1/28 , C08L3/18
摘要: A water insoluble, biocompatible gel is prepared by reacting carboxymethylcellulose and a carbodiimide, wherein the reaction is conducted in an aqueous medium containing a water miscible organic solvent, such as a lower alkanol, an alkyl pyrrolidone, DMSO or acetone. The present method permits the reaction to contain higher concentrations of carboxymethycellylose and less carbodiimide than conventional methods.
摘要翻译: 通过使羧甲基纤维素和碳二亚胺反应制备水不溶性生物相容性凝胶,其中反应在含有水混溶性有机溶剂如低级烷醇,烷基吡咯烷酮,DMSO或丙酮的水性介质中进行。 本方法允许反应含有比常规方法更高浓度的羧甲基纤维素和较少的碳二亚胺。
-
-
-
-
-
-
-